Moderate to Severe
Crohn's Disease
Menu

Considering a new
Crohn's disease treatment?

Your current treatment may not have your moderate to severe Crohn's under control if you still have symptoms such as:

It’s important to speak with your doctor about your symptoms.
You may be working around your symptoms if you:

Take our Workaround Quiz to learn about how your symptoms may be affecting you.

This quiz helps you to find out if you are using workarounds to manage your Crohn's symptoms. After taking the quiz, talk to your doctor about whether it’s time for a change.


Discuss Crohn's treatment goals with your doctor and ask about HUMIRA.

What are your needs and expectations from your Crohn's disease medication and treatment plan? Communicating your personal goals of treatment is an important part of the conversation that you have with your doctor. It is also important to be open and honest with your doctor about what you are experiencing. Your doctor will work with you to develop a plan.

discuss your Crohn’s treatment goals with your gastroenterologist

According to the American College of Gastroenterology, one of the main goals of Crohn's disease treatment is remission (few or no symptoms). If your current treatment is not keeping your Crohn's in control, talk to your doctor about HUMIRA.

Remission is possible with HUMIRA.

In 2 clinical studies, more than half of the patients who took HUMIRA had significant symptom relief, versus about 1 out of 3 who took placebo.

In the same studies, 36% and 21% of patients who took HUMIRA achieved remission, versus 12% and 7% who took placebo. Results were at 4 weeks.

HUMIRA is not right for everyone. Only your doctor can decide if HUMIRA is right for you.

Learn to Talk About Treatment Goals with Your Doctor with the Doctor Discussion Guide

Many Crohn's symptoms may be caused by inflammation.

Crohn’s disease symptoms are caused by inflammation in the intestines.

Many people with immune-mediated inflammatory diseases such as Crohn's disease produce too much tumor necrosis factor (TNF). TNF is a protein that is found in your body and is part of your immune system. However, in patients with Crohn's disease, this this overproduction of TNF can cause inflammation in the digestive or gastrointestinal (GI) tract, which can contribute to Crohn's symptoms.

HUMIRA targets and helps block TNF-alpha.

HUMIRA belongs to a class of biologic medicines known as TNF blockers. Overproduction of TNF in the GI tract is associated with Crohn's disease. HUMIRA specifically binds to TNF to block its action. This helps reduce the inflammation that can lead to Crohn's symptoms.

Learn More About How HUMIRA Works to Help Treat Crohn's Disease

HUMIRA gives you the option to administer at home.

If your doctor decides that you are able to give your injections at home, you should receive training by a health care professional on the right way to prepare and inject HUMIRA. Do not try to inject HUMIRA yourself until you have been shown the right way to give the injections. Your first injection must be given under the supervision of a health care professional.

HUMIRA offers the independence of self-administration. You may not have to schedule an appointment in order to take your medication at a doctor's office, because you can take HUMIRA in the comfort of your home. HUMIRA is typically taken every other week, after an initial starting dose, and requires refrigeration until administration. Your doctor will follow up with you on a regular basis. Refer to the Patient Instructions for Use for the HUMIRA Pen or the prefilled syringe and the Medication Guide for more information.

Common side effects of HUMIRA

Common side effects of HUMIRA include injection site reactions (redness, rash, swelling, itching, or bruising), upper respiratory infections (sinus infections), headaches, rash, and nausea. These are not all of the possible side effects with HUMIRA. Tell your doctor if you have any side effect that bothers you or that does not go away.

If you ever need additional help with self-injection, HUMIRA offers a range of support services for patients. You can:

See All the Ways You Can Get HUMIRA Injection Help

Your first 4 weeks on HUMIRA

Important: You must pay attention to your starting dose—it is different than your maintenance dose and is a critical part of taking HUMIRA as prescribed.

You’ll get complete instructions and information in the Crohn's Disease/Ulcerative Colitis Starter Package provided with your first prescription of HUMIRA.

Starting Dose

Day 1*
4 HUMIRA Pens (160 mg) On day 1 you will inject 4 HUMIRA Pens (160 mg). On day 15 you will inject 2 HUMIRA Pens (80 mg) On day 1 you will inject 4 HUMIRA Pens (160 mg). On day 15 you will inject 2 HUMIRA Pens (80 mg) On day 1 you will inject 4 HUMIRA Pens (160 mg). On day 15 you will inject 2 HUMIRA Pens (80 mg) On day 1 you will inject 4 HUMIRA Pens (160 mg). On day 15 you will inject 2 HUMIRA Pens (80 mg)
Day 15
2 HUMIRA Pens (80 mg) On day 1 you will inject 4 HUMIRA Pens (160 mg). On day 15 you will inject 2 HUMIRA Pens (80 mg) On day 1 you will inject 4 HUMIRA Pens (160 mg). On day 15 you will inject 2 HUMIRA Pens (80 mg)

Continuing Dose

Day 29 and every
other week thereafter
1 HUMIRA Pen (40 mg) on Day 29 and every other week thereafter you will begin your regularly scheduled does of 1 HUMIRA Pen (40 mg) every other week. On Day 29 you will begin your regularly scheduled dose of 1 HUMIRA Pen (40 mg) every other week.

*First dose can be administered as 4 injections in 1 day or as 2 injections per day for 2 consecutive days.


Your commitment is key.

Make sure to talk to your doctor if you have any questions, concerns, or comments about taking HUMIRA. It's important to realize that in order for HUMIRA to work, you must take it as prescribed.

If you are feeling better after taking HUMIRA, that's great. Do not stop taking HUMIRA unless your doctor tells you to stop. Some patients taking HUMIRA may think they can stop their treatment and still experience fewer Crohn's flares. But HUMIRA has been shown to maintain symptom improvement in a clinical study when taken regularly, as scheduled, every other week. Some patients may start to see relief in as little as 4 weeks. If you do not notice symptom improvement within 12 weeks, you should discuss your results with your doctor. Individual results may vary.

Your safety is important to us.
Learn about our Important Safety Information.

IMPORTANT SAFETY INFORMATION
ABOUT HUMIRA® (adalimumab)1

Next Page: How HUMIRA Works

What is the most important information I should know about HUMIRA?

You should discuss the potential benefits and risks of HUMIRA with your doctor. HUMIRA is a TNF blocker medicine that can lower the ability of your immune system to fight infections. You should not start taking HUMIRA if you have any kind of infection unless your doctor says it is okay.

  • Serious infections have happened in people taking HUMIRA. These serious infections include tuberculosis (TB) and infections caused by viruses, fungi, or bacteria that have spread throughout the body. Some people have died from these infections. Your doctor should test you for TB before starting HUMIRA, and check you closely for signs and symptoms of TB during treatment with HUMIRA. If your doctor feels you are at risk, you may be treated with medicine for TB.

  • Cancer. For children and adults taking TNF blockers, including HUMIRA, the chance of getting lymphoma or other cancers may increase. There have been cases of unusual cancers in children, teenagers, and young adults using TNF blockers. Some people have developed a rare type of cancer called hepatosplenic T-cell lymphoma. This type of cancer often results in death. If using TNF blockers including HUMIRA, your chance of getting two types of skin cancer (basal cell and squamous cell) may increase. These types are generally not life-threatening if treated; tell your doctor if you have a bump or open sore that doesn’t heal.


What should I tell my doctor BEFORE starting HUMIRA?

Tell your doctor about all of your health conditions, including if you:

  • Have an infection, are being treated for infection, or have symptoms of an infection
  • Get a lot of infections or infections that keep coming back
  • Have diabetes
  • Have TB or have been in close contact with someone with TB, or were born in, lived in, or traveled where there is more risk for getting TB
  • Live or have lived in an area (such as the Ohio and Mississippi River valleys) where there is an increased risk for getting certain kinds of fungal infections, such as histoplasmosis, coccidioidomycosis, or blastomycosis
  • Have or have had hepatitis B
  • Are scheduled for major surgery
  • Have or have had cancer
  • Have numbness or tingling or a nervous system disease such as multiple sclerosis or Guillain-Barré syndrome
  • Have or had heart failure
  • Have recently received or are scheduled to receive a vaccine. HUMIRA patients may receive vaccines, except for live vaccines
  • Are allergic to rubber, latex, or any HUMIRA ingredients
  • Are pregnant, planning to become pregnant, breastfeeding, or planning to breastfeed

Also tell your doctor about all the medicines you take. You should not take HUMIRA with ORENCIA® (abatacept), KINERET® (anakinra), REMICADE® (infliximab), ENBREL® (etanercept), CIMZIA® (certolizumab pegol), or SIMPONI® (golimumab). Tell your doctor if you have ever used RITUXAN® (rituximab), IMURAN® (azathioprine), or PURINETHOL® (mercaptopurine, 6-MP).


What should I watch for AFTER starting HUMIRA?

HUMIRA can cause serious side effects, including:

  • Serious infections. These include TB and infections caused by viruses, fungi, or bacteria. Symptoms related to TB include a cough, low-grade fever, weight loss, or loss of body fat and muscle.
  • Hepatitis B infection in carriers of the virus. Symptoms include muscle aches, feeling very tired, dark urine, skin or eyes that look yellow, little or no appetite, vomiting, clay-colored bowel movements, fever, chills, stomach discomfort, and skin rash.
  • Allergic reactions. Symptoms of a serious allergic reaction include hives, trouble breathing, and swelling of your face, eyes, lips, or mouth.
  • Nervous system problems. Signs and symptoms include numbness or tingling, problems with your vision, weakness in your arms or legs, and dizziness.
  • Blood problems. Symptoms include a fever that does not go away, bruising or bleeding very easily, or looking very pale.
  • Heart failure (new or worsening). Symptoms include shortness of breath, swelling of your ankles or feet, and sudden weight gain.
  • Immune reactions including a lupus-like syndrome. Symptoms include chest discomfort or pain that does not go away, shortness of breath, joint pain, or rash on your cheeks or arms that gets worse in the sun.
  • Liver problems. Symptoms include feeling very tired, skin or eyes that look yellow, poor appetite or vomiting, and pain on the right side of your stomach (abdomen).
  • Psoriasis (new or worsening). Symptoms include red scaly patches or raised bumps that are filled with pus.

Call your doctor or get medical care right away if you develop any of the above symptoms.


Common side effects of HUMIRA include injection site reactions (redness, rash, swelling, itching, or bruising), upper respiratory infections (sinus infections), headaches, rash, and nausea. These are not all of the possible side effects with HUMIRA. Tell your doctor if you have any side effect that bothers you or that does not go away.


Remember, tell your doctor right away if you have an infection or symptoms of an infection, including:

  • Fever, sweats, or chills
  • Muscle aches
  • Cough
  • Shortness of breath
  • Blood in phlegm
  • Weight loss
  • Warm, red, or painful skin or sores on your body
  • Diarrhea or stomach pain
  • Burning when you urinate
  • Urinating more often than normal
  • Feeling very tired

HUMIRA is given by injection under the skin.


This is the most important information to know about HUMIRA. For more information, talk to your health care provider.

 

Uses

 

HUMIRA is a prescription medicine used:

  • To reduce the signs and symptoms of:
    • Moderate to severe rheumatoid arthritis (RA) in adults. HUMIRA can be used alone, with methotrexate, or with certain other medicines. HUMIRA may prevent further damage to your bones and joints and may help your ability to perform daily activities.
    • Moderate to severe polyarticular juvenile idiopathic arthritis (JIA) in children 2 years of age and older. HUMIRA can be used alone, with methotrexate, or with certain other medicines.
    • Psoriatic arthritis (PsA) in adults. HUMIRA can be used alone or with certain other medicines. HUMIRA may prevent further damage to your bones and joints and may help your ability to perform daily activities.
    • Ankylosing spondylitis (AS) in adults.
    • Moderate to severe Crohn's disease (CD) and to achieve and maintain clinical remission in adults who have not responded well to conventional treatments. HUMIRA is also used to reduce signs and symptoms and to achieve clinical remission in these adults who have lost response to or are unable to tolerate infliximab.
    • Moderate to severe Crohn's disease (CD) and to achieve and maintain clinical remission in children 6 years of age and older when certain other treatments have not worked well enough.
  • In adults, to help get moderate to severe ulcerative colitis (UC) under control (induce remission) and keep it under control (sustain remission) when certain other medicines have not worked well enough. It is not known if HUMIRA is effective in people who stopped responding to or could not tolerate anti-TNF medicines.
  • To treat moderate to severe chronic plaque psoriasis (Ps) in adults who are ready for systemic therapy or phototherapy, and are under the care of a doctor who will decide if other systemic therapies are less appropriate.

64H-1598805

In This Section

Get the Doctor
Discussion Guide
and get the most
from your next
appointment.

Get the Guide

Being prepared
helps you:

Understand your condition
Give your doctor more insight


Please see the Full Prescribing Information, including the Medication Guide, for HUMIRA.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

If you cannot afford your medication, contact: www.pparx.org or call the toll-free phone number (1-888-4PPA-NOW) for assistance.

Please see accompanying full Prescribing Information, including Patient Instructions for Use in the Medication Guide and discuss it with your doctor.

Legal Notices/Privacy Policy. Copyright 2013, AbbVie Inc., North Chicago, Illinois, U.S.A. If you have any questions about AbbVie’s HUMIRA.com website that have not been answered click here. This website and the information contained herein is intended for use by US residents only, is provided for informational purposes only and is not intended to replace a discussion with a healthcare provider. All decisions regarding patient care must be made with a healthcare provider and consider the unique characteristics of each patient.

Reference: 1. HUMIRA Injection [package insert]. North Chicago, IL: AbbVie Inc.

1299985-1211617

HUMIRA Use1

HUMIRA is a prescription medicine used to reduce signs and symptoms, and to achieve and maintain clinical remission in adults with moderate to severe Crohn’s disease who have not responded well to conventional treatments. HUMIRA is also used to reduce signs and symptoms and achieve clinical remission in these adults who have also lost response to or are unable to tolerate infliximab.

SAFETY CONSIDERATIONS1

Serious infections have happened in people taking HUMIRA. These serious infections include tuberculosis (TB) and infections caused by viruses, fungi, or bacteria that have spread throughout the body. Some people have died from these infections. HUMIRA may increase the chance of getting lymphoma, including a rare kind, or other cancers. HUMIRA can cause serious side effects including hepatitis B infection in carriers of the virus, allergic reactions, nervous system problems, blood problems, heart failure, certain immune reactions including a lupus-like syndrome, liver problems, and new or worsening psoriasis.